ATC Group: D10AF Antiinfectives for treatment of acne

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D10AF in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D10 Anti-acne preparations
3 D10A Anti-acne preparations for topical use
4 D10AF Antiinfectives for treatment of acne

Group D10AF contents

Code Title
D10AF01 Clindamycin
D10AF02 Erythromycin
D10AF03 Chloramphenicol
D10AF04 Meclocycline
D10AF05
D10AF06
D10AF07
D10AF51 Clindamycin, combinations
D10AF52 Erythromycin, combinations

Active ingredients in D10AF

Active Ingredient

Chloramphenicol is a broad spectrum antibiotic which has activity against many types of Gram-positive and Gram-negative bacteria. It acts by interfering with bacterial protein synthesis. Chloramphenicol is widely distributed in body tissues and fluids and enters the cerebrospinal fluid.

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.

Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.

Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines.

The sulfonamides are bacteriostatic agents and the spectrum of activity is similar for all. Sulfonamides inhibit bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with aminobenzoic acid through competitive inhibition of the enzyme dihydropteroate synthetase.

Related product monographs

Document Type Information Source  
 AKNEMYCIN PLUS Cutaneous solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 CLINDOXYL Gel MPI, Generic Health Products Regulatory Authority (ZA)
 DALACIN C Capsule MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)
 DALACIN CREAM Vaginal Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DALACIN T Topical solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ZINDACLIN Gel MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ZINERYT Powder and solvent for solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)